| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Ca2+ release mechanism gated by the novel pyridine nucleotide, NAADP
|
Genazzani, Armando A.
|
|
1997
|
18 |
4 |
p. 108-110
3 p.
|
artikel
|
| 2 |
Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease
|
Richardson, Peter J.
|
|
1997
|
18 |
4 |
p. 338-344
7 p.
|
artikel
|
| 3 |
Adenosine in the mammalian heart: nothing to get excited about
|
Pelleg, Amir
|
|
1997
|
18 |
4 |
p. 236-238
3 p.
|
artikel
|
| 4 |
Agonist-specific receptor conformations
|
Kenakin, Terry
|
|
1997
|
18 |
4 |
p. 416-417
2 p.
|
artikel
|
| 5 |
Anaesthetics in a bind?
|
Peters, John A.
|
|
1997
|
18 |
4 |
p. 454-455
2 p.
|
artikel
|
| 6 |
Any facts behind the DHEA hype?
|
Bastianetto, Stéphane
|
|
1997
|
18 |
4 |
p. 447-449
3 p.
|
artikel
|
| 7 |
A protein-mediated mechanism for the DNA sequence-specific action of topoisomerase II poisons
|
Capranico, Giovanni
|
|
1997
|
18 |
4 |
p. 323-329
7 p.
|
artikel
|
| 8 |
Association of β 3-adrenoceptor polymorphism with obesity and diabetes: current status
|
Strosberg, A.Donny
|
|
1997
|
18 |
4 |
p. 449-454
6 p.
|
artikel
|
| 9 |
A three-state receptor model of agonist action
|
Leff, Paul
|
|
1997
|
18 |
4 |
p. 355-362
8 p.
|
artikel
|
| 10 |
Author index
|
|
|
1997
|
18 |
4 |
p. 493-495
3 p.
|
artikel
|
| 11 |
Autonomic pharmacology
|
Kennedy, Charles
|
|
1997
|
18 |
4 |
p. 259-
1 p.
|
artikel
|
| 12 |
Books reviewed index
|
|
|
1997
|
18 |
4 |
p. 506-
1 p.
|
artikel
|
| 13 |
Bristol-Myers squibb unrestricted biomedical research grants programme
|
Lazdunski,
|
|
1997
|
18 |
4 |
p. 151-152
2 p.
|
artikel
|
| 14 |
CA1A2X-competitive inhibitors of farnesyltransferase as anti-cancer agents
|
Omer, Charles A.
|
|
1997
|
18 |
4 |
p. 437-444
8 p.
|
artikel
|
| 15 |
Calcineurin regulation of synaptic function: from ion channels to transmitter release and gene transcription
|
Yakel, Jerrel L.
|
|
1997
|
18 |
4 |
p. 124-134
11 p.
|
artikel
|
| 16 |
Changing the countenance of pharmacology courses in medical schools
|
Rodriguez, Rodolfo
|
|
1997
|
18 |
4 |
p. 314-318
5 p.
|
artikel
|
| 17 |
Clinical and molecular aspects of motoneurone diseases: animal models, neurotrophic factors and Bcl-2 oncoprotein
|
Sagot, Yves
|
|
1997
|
18 |
4 |
p. 330-337
8 p.
|
artikel
|
| 18 |
Clinical development of endothelin receptor antagonists
|
Douglas, Stephen A.
|
|
1997
|
18 |
4 |
p. 408-412
5 p.
|
artikel
|
| 19 |
Coleman replies
|
Coleman, Robert A.
|
|
1997
|
18 |
4 |
p. 150-151
2 p.
|
artikel
|
| 20 |
Contents
|
|
|
1997
|
18 |
4 |
p. v-xi
nvt p.
|
artikel
|
| 21 |
Curzon et al. reply
|
Curzon, Gerald
|
|
1997
|
18 |
4 |
p. 191-192
2 p.
|
artikel
|
| 22 |
Differences between natural and recombinant G protein-coupled receptor systems with varying receptor/G protein stoichiometry
|
Kenakin, Terry
|
|
1997
|
18 |
4 |
p. 456-464
9 p.
|
artikel
|
| 23 |
Drug prototypes and their exploitation
|
Timmerman, H.
|
|
1997
|
18 |
4 |
p. 259-260
2 p.
|
artikel
|
| 24 |
Editorial
|
|
|
1997
|
18 |
4 |
p. 258-
1 p.
|
artikel
|
| 25 |
Electrophysiological pharmacology of the autoreceptor-mediated responses of dopaminergic cells to antiparkinsonian drugs
|
Mercuri, Nicola B.
|
|
1997
|
18 |
4 |
p. 232-235
4 p.
|
artikel
|
| 26 |
Endocytosis and recycling of G protein-coupled receptors
|
Koenig, Jennifer A.
|
|
1997
|
18 |
4 |
p. 276-287
12 p.
|
artikel
|
| 27 |
Endogenous mediators that inhibit the leukocyte-endothelium interaction
|
Perretti, Mauro
|
|
1997
|
18 |
4 |
p. 418-425
8 p.
|
artikel
|
| 28 |
Endothelium-derived hyperpolarizing factor(s): updating the unknown
|
Mombouli, Jean-Vivien
|
|
1997
|
18 |
4 |
p. 252-256
5 p.
|
artikel
|
| 29 |
Eosinophil lysis and free granules: an in vivo paradigm for cell activation and drug development
|
Persson, Carl G.A.
|
|
1997
|
18 |
4 |
p. 117-123
7 p.
|
artikel
|
| 30 |
Errata
|
|
|
1997
|
18 |
4 |
p. 345-346
2 p.
|
artikel
|
| 31 |
Errata
|
|
|
1997
|
18 |
4 |
p. 181-
1 p.
|
artikel
|
| 32 |
Estrogens, progestins and their antagonists vols 1 and 2
|
Favoni, R.E.
|
|
1997
|
18 |
4 |
p. 182-
1 p.
|
artikel
|
| 33 |
Fluoxetine hypophagia
|
Clifton, Peter G.
|
|
1997
|
18 |
4 |
p. 191-
1 p.
|
artikel
|
| 34 |
Frölich replies to botting and vane
|
Frölich, J.C.
|
|
1997
|
18 |
4 |
p. 313-
1 p.
|
artikel
|
| 35 |
Frolich replies to Griswold et al.
|
Frölich, J.C.
|
|
1997
|
18 |
4 |
p. 312-
1 p.
|
artikel
|
| 36 |
Gene targeting — homing in on α 2-adrenoceptor-subtype function
|
MacDonald, Ewen
|
|
1997
|
18 |
4 |
p. 211-219
9 p.
|
artikel
|
| 37 |
Gorenne et al. reply
|
Gorenne, I.
|
|
1997
|
18 |
4 |
p. 148-149
2 p.
|
artikel
|
| 38 |
Hagan et al. reply
|
Hagan, J.J.
|
|
1997
|
18 |
4 |
p. 310-
1 p.
|
artikel
|
| 39 |
Human genome project Europe
|
Williamson, Alan R.
|
|
1997
|
18 |
4 |
p. 303-305
3 p.
|
artikel
|
| 40 |
Identifying neuronal non-L Ca2+ channels — more than stamp collecting?
|
Nooney, Janet M.
|
|
1997
|
18 |
4 |
p. 363-371
9 p.
|
artikel
|
| 41 |
Improved therapies for Parkinson's disease: life beyond dopamine D2 D3 receptors agonists
|
Williams, Michael
|
|
1997
|
18 |
4 |
p. 307-310
4 p.
|
artikel
|
| 42 |
Inducible receptors
|
Donaldson, Lucy F.
|
|
1997
|
18 |
4 |
p. 171-181
11 p.
|
artikel
|
| 43 |
Interstitial cells of Cajal as targets for pharmacological intervention in gastrointestinal motor disorders
|
Huizinga, Jan D.
|
|
1997
|
18 |
4 |
p. 393-403
11 p.
|
artikel
|
| 44 |
Inverse agonism and the regulation of receptor number
|
Milligan, Graeme
|
|
1997
|
18 |
4 |
p. 468-474
7 p.
|
artikel
|
| 45 |
Investigation of receptors responsive to pyrimidines
|
Connolly, Gerald P.
|
|
1997
|
18 |
4 |
p. 413-414
2 p.
|
artikel
|
| 46 |
Ionotropic glutamate receptors: new types and new concepts
|
Barnard, Eric A.
|
|
1997
|
18 |
4 |
p. 141-148
8 p.
|
artikel
|
| 47 |
Is the R and R∗ dichotomy real?
|
Tuček, Stanislav
|
|
1997
|
18 |
4 |
p. 414-416
3 p.
|
artikel
|
| 48 |
Is there a nociceptive carousel?
|
Urban, Laszlo
|
|
1997
|
18 |
4 |
p. 223-224
2 p.
|
artikel
|
| 49 |
Knowledge and skills needs of pharmacology graduates in first employment: how do pharmacology courses measure up?
|
Hughes, Ian
|
|
1997
|
18 |
4 |
p. 111-116
6 p.
|
artikel
|
| 50 |
Looking good at number ten Autonomic-endocrine interactions
|
Vellucci, Sandra
|
|
1997
|
18 |
4 |
p. 301-
1 p.
|
artikel
|
| 51 |
Metabotropic GABAB receptors cloned at last
|
Bowery, Norman G.
|
|
1997
|
18 |
4 |
p. 103-
1 p.
|
artikel
|
| 52 |
More on the classification of cysteinyl leukotriene receptors
|
Rovati, G.E.
|
|
1997
|
18 |
4 |
p. 148-
1 p.
|
artikel
|
| 53 |
Nitric oxide: inducer or suppressor of apoptosis?
|
Nicotera, Pierluigi
|
|
1997
|
18 |
4 |
p. 189-190
2 p.
|
artikel
|
| 54 |
Nitric oxide supplementation or synthesis block — which is the better approach to treatment of heart disease?
|
Curtis, Michael J.
|
|
1997
|
18 |
4 |
p. 239-244
6 p.
|
artikel
|
| 55 |
Nonpeptide antagonists of neuropeptide receptors: tools for research and therapy
|
Betancur, Catalina
|
|
1997
|
18 |
4 |
p. 372-386
15 p.
|
artikel
|
| 56 |
Oestrogen/growth factor cross-talk in breast carcinoma: a specific target for novel antioestrogens
|
de Cupis, Alessandra
|
|
1997
|
18 |
4 |
p. 245-251
7 p.
|
artikel
|
| 57 |
On criteria for functional β 3-adrenoceptors
|
Molenaar, Peter
|
|
1997
|
18 |
4 |
p. 258-
1 p.
|
artikel
|
| 58 |
Orphan G protein-coupled receptors: a neglected opportunity for pioneer drug discovery
|
Stadel, Jeffrey M.
|
|
1997
|
18 |
4 |
p. 430-437
8 p.
|
artikel
|
| 59 |
Oxygen-sensitive ion channels
|
Peers, Chris
|
|
1997
|
18 |
4 |
p. 405-408
4 p.
|
artikel
|
| 60 |
Parkinson's disease: prospects for improved drug therapy
|
Hagan, Jim J.
|
|
1997
|
18 |
4 |
p. 156-163
8 p.
|
artikel
|
| 61 |
Pharmacological properties of β 3-adrenoceptors
|
Nisoli, Enzo
|
|
1997
|
18 |
4 |
p. 257-258
2 p.
|
artikel
|
| 62 |
Pharmacotherapy of alcohol dependence
|
Zernig, Gerald
|
|
1997
|
18 |
4 |
p. 229-231
3 p.
|
artikel
|
| 63 |
Phosphodiesterase (PDE)4 inhibitors: anti-inflammatory drugs of the future?
|
Teixeira, Mauro M.
|
|
1997
|
18 |
4 |
p. 164-170
7 p.
|
artikel
|
| 64 |
Pitfalls using metalloporphyrins in carbon monoxide research
|
Grundemar, Lars
|
|
1997
|
18 |
4 |
p. 193-195
3 p.
|
artikel
|
| 65 |
Potassium channels still hot
|
Grissmer, Stephan
|
|
1997
|
18 |
4 |
p. 347-350
4 p.
|
artikel
|
| 66 |
Potential signalling roles for UTP and UDP: sources, regulation and release of uracil nucleotides
|
Anderson, Christopher M.
|
|
1997
|
18 |
4 |
p. 387-392
6 p.
|
artikel
|
| 67 |
Re-addressing relative selectivities
|
Botting, R.
|
|
1997
|
18 |
4 |
p. 312-
1 p.
|
artikel
|
| 68 |
Receptor signal transduction protocols
|
Strosberg, A.Donny
|
|
1997
|
18 |
4 |
p. 446-
1 p.
|
artikel
|
| 69 |
Re-classification of NSAIDs
|
Griswold, Don E.
|
|
1997
|
18 |
4 |
p. 311-
1 p.
|
artikel
|
| 70 |
Release of soluble nucleotidases: a novel mechanism for neurotransmitter inactivation?
|
Kennedy, Charles
|
|
1997
|
18 |
4 |
p. 263-266
4 p.
|
artikel
|
| 71 |
Royal society muller award
|
|
|
1997
|
18 |
4 |
p. 306-
1 p.
|
artikel
|
| 72 |
Schizophrenia and L-745, 870, a novel dopamine D4 receptor antagonist
|
Bristow, Linda J.
|
|
1997
|
18 |
4 |
p. 186-188
3 p.
|
artikel
|
| 73 |
Selective inhibitors of neuronal nitric oxide synthase — is no NOS really good NOS for the nervous system?
|
Moore, Philip K.
|
|
1997
|
18 |
4 |
p. 204-211
8 p.
|
artikel
|
| 74 |
Soluble guanylate cyclase: the forgotten sibling
|
Hobbs, Adrian J.
|
|
1997
|
18 |
4 |
p. 484-491
8 p.
|
artikel
|
| 75 |
Stress, hormonal changes, alcohol, food constituents and drugs: factors that advance the incidence of tobacco smoke-related cancer?
|
Maser, Edmund
|
|
1997
|
18 |
4 |
p. 270-275
6 p.
|
artikel
|
| 76 |
Subject index
|
|
|
1997
|
18 |
4 |
p. 497-505
9 p.
|
artikel
|
| 77 |
Synthetic functions of airway smooth muscle in asthma
|
Johnson, Simon R.
|
|
1997
|
18 |
4 |
p. 288-292
5 p.
|
artikel
|
| 78 |
Targeting ischaemia - cell swelling and drug efficacy
|
Wright, Anthony R.
|
|
1997
|
18 |
4 |
p. 224-228
5 p.
|
artikel
|
| 79 |
The benzodiazepine binding site of GABAA receptors
|
Sigel, Erwin
|
|
1997
|
18 |
4 |
p. 425-429
5 p.
|
artikel
|
| 80 |
The camptothecins: from discovery to the patient
|
Capranico, Giovanni
|
|
1997
|
18 |
4 |
p. 445-446
2 p.
|
artikel
|
| 81 |
The cross-talk between nitric oxide and Ca2+: a story with a complex past and a promising future
|
Clementi, Emilio
|
|
1997
|
18 |
4 |
p. 266-269
4 p.
|
artikel
|
| 82 |
The dual nature of the tachykinin NK1 receptor
|
Maggi, Carlo A.
|
|
1997
|
18 |
4 |
p. 351-355
5 p.
|
artikel
|
| 83 |
The GABA receptors
|
Smith, Geoffrey B.
|
|
1997
|
18 |
4 |
p. 260-261
2 p.
|
artikel
|
| 84 |
The 5-HT7 receptor: orphan found
|
Eglen, Richard M.
|
|
1997
|
18 |
4 |
p. 104-107
4 p.
|
artikel
|
| 85 |
The interaction between salmeterol and the β 2-adrenoceptor protein
|
Jack, David
|
|
1997
|
18 |
4 |
p. 149-150
2 p.
|
artikel
|
| 86 |
The mouse trap
|
Persson, Carl G.A.
|
|
1997
|
18 |
4 |
p. 465-467
3 p.
|
artikel
|
| 87 |
The orphan opioid receptor and its endogenous ligand — nociceptin/orphanin FQ
|
Henderson, Graeme
|
|
1997
|
18 |
4 |
p. 293-300
8 p.
|
artikel
|
| 88 |
Therapeutic advances in amyotrophic lateral sclerosis
|
Louvel, Erik
|
|
1997
|
18 |
4 |
p. 196-203
8 p.
|
artikel
|
| 89 |
The real life of voltage-gated K+ channels: more than model behaviour
|
Robertson, Brian
|
|
1997
|
18 |
4 |
p. 474-483
10 p.
|
artikel
|
| 90 |
The role of excitotoxicity in organophosphorous nerve agents central poisoning
|
Solber, Yoram
|
|
1997
|
18 |
4 |
p. 183-185
3 p.
|
artikel
|
| 91 |
Time to reassess chiral aspects of β-adrenoceptor antagonists
|
Stoschitzky, Kurt
|
|
1997
|
18 |
4 |
p. 306-307
2 p.
|
artikel
|
| 92 |
Tumour necrosis factor α and interleukin 1 signalling: do MAPKK kinases connect it all?
|
Eder, Jörg
|
|
1997
|
18 |
4 |
p. 319-322
4 p.
|
artikel
|
| 93 |
What is pharmacology? A discussion
|
Laurence, Desmond
|
|
1997
|
18 |
4 |
p. 153-155
3 p.
|
artikel
|
| 94 |
Where is the locus in opioid withdrawal?
|
Christie, MacDonald J.
|
|
1997
|
18 |
4 |
p. 134-140
7 p.
|
artikel
|
Tijdschrift beschrijving